Asaf Iram

Investment Manager

Izraeli CPA, Ronit

CFO

Shula Recanati

Managing Partner

Leon Recanati

Founder, Chairman and CEO

31 past transactions

Quris

Seed Round in 2022
Quris Technologies is a bio-AI clinical-prediction platform is being developed to assure the safety and efficacy of medications. The company provides a fully automated, self-training AI platform accurately predicts clinical safety and efficacy for novel drugs faster and more cost-effectively while minimizing animal testing, allowing pharma companies to avoid the enormous risks and costs of failed clinical trials and end the reliance on ineffective animal testing. Quris Technologies was established in 2019 by Isaac Bentwich in Tel Aviv, Israel.

Cylus

Series B in 2021
Cylus was founded to help mainline and urban railway companies avoid safety incidents and service disruptions caused by cyber-attacks. ‍ Cylus offers solutions that are specifically designed to address the unique requirements and needs of the railway industry, enabling to detect cyber threats in signaling and control networks, trackside and onboard, facilitating an effective response before harm happens. ‍ Led by veterans from the elite technological unit of the Israel Defense Forces’ Intelligence Corps, together with top executives from the railway industry, Cylus’ team combines deep expertise in cybersecurity and rail.

Karamba Security

Series B in 2021
Karamba Security's patented software detects and prevents cyberattacks on a wide variety of connected devices and systems, including automotive ECUs, Industry 4.0 controllers, enterprise edge devices, and IoT endpoints. Karamba's security solutions are embedded within devices and work automatically, without any need for customer operation and with negligible performance impact.

Lydus Medical

Seed Round in 2021
Lydus Medical is a start-up company that develops a set of tools for anastomosis of small blood vessels. The company was founded in 2017 and is headquartered in Kfar Saba, Israel.

Nurami Medical

Series B in 2020
Nurami Medical is dedicated to the development of a surgical scaffold platform for the repair, regeneration and safe healing of soft tissues following internal surgeries. Nurami Medical production technology is based on the electrospinning technique.

Model 9

Series A in 2020
Model9 modernizes mainframe data management and business intelligence in large enterprises and helps them accelerate the adoption of hybrid cloud technologies and benefit from cloud economics. Its patented technology delivers mainframe data to any cloud or on-premise storage platform, eliminating tape and virtual tape, and enabling secure integration with advanced analytics tools. Model9 is trusted by the world's leading financial institutions, government agencies and transportation companies. It is a graduate of the IBM AlphaZone startup program as well as an AWS Advanced Technology Partner.

capitalise.ai

Funding Round in 2019
Capitalise is the innovative and magical way that lets you use natural language to make your investment ideas come to life. Capitalise simplifies the investment process by taking simple words and converting them into executable and optimized investments. We bridge between the simplicity of common words and the complex world of automated trading. Capitalise delivers portfolio management automation based on written investment scenarios. With Capitalise you can instantly optimize your investment ideas to analyze, predict and improve investment performance.

Cylus

Series B in 2019
Cylus was founded to help mainline and urban railway companies avoid safety incidents and service disruptions caused by cyber-attacks. ‍ Cylus offers solutions that are specifically designed to address the unique requirements and needs of the railway industry, enabling to detect cyber threats in signaling and control networks, trackside and onboard, facilitating an effective response before harm happens. ‍ Led by veterans from the elite technological unit of the Israel Defense Forces’ Intelligence Corps, together with top executives from the railway industry, Cylus’ team combines deep expertise in cybersecurity and rail.

Ecoppia

Venture Round in 2017
With over 16GW of signed agreements, Ecoppia (TASE: ECPA) is a pioneer and world leader in robotic cleaning solutions for PV modules, keeping them clean, at year-round peak performance. Ecoppia's water-free, fully automated robotic solutions prevent soiling losses and potential damage, using advanced Business Intelligence capabilities. Remotely managed, Ecoppia's platform allows utility-scale solar sites to achieve optimal performance with minimal human intervention and lower LCOE. Ecoppia’s proprietary algorithms and robotic solutions make day-to-day O&M at solar sites safer, more efficient, and more reliable. Our clients enjoy the benefits of a cloud-based, data-driven platform, allowing them to reach their full potential while ensuring their constant growth and scalability. Publicly held and backed by prominent international investment funds, Ecoppia provides revolutionized solar ROIs for leading Tier1 energy conglomerates worldwide, cleaning millions of solar panels every month.

Model 9

Seed Round in 2017
Model9 modernizes mainframe data management and business intelligence in large enterprises and helps them accelerate the adoption of hybrid cloud technologies and benefit from cloud economics. Its patented technology delivers mainframe data to any cloud or on-premise storage platform, eliminating tape and virtual tape, and enabling secure integration with advanced analytics tools. Model9 is trusted by the world's leading financial institutions, government agencies and transportation companies. It is a graduate of the IBM AlphaZone startup program as well as an AWS Advanced Technology Partner.

Karamba Security

Series A in 2016
Karamba Security's patented software detects and prevents cyberattacks on a wide variety of connected devices and systems, including automotive ECUs, Industry 4.0 controllers, enterprise edge devices, and IoT endpoints. Karamba's security solutions are embedded within devices and work automatically, without any need for customer operation and with negligible performance impact.

CyberX

Series A in 2016
Funded by Norwest Venture Partners, Qualcomm Ventures and other leading venture firms, CyberX delivers the only cybersecurity platform built by blue-team experts with a track record of defending critical national infrastructure. That difference is the foundation for the most widely deployed platform for continuously reducing IoT/OT risk and preventing costly outages, safety and environmental incidents, theft of intellectual property, and operational inefficiencies. For more information, visit CyberX.io or follow @CyberX_Labs.

Karamba Security

Seed Round in 2016
Karamba Security's patented software detects and prevents cyberattacks on a wide variety of connected devices and systems, including automotive ECUs, Industry 4.0 controllers, enterprise edge devices, and IoT endpoints. Karamba's security solutions are embedded within devices and work automatically, without any need for customer operation and with negligible performance impact.

LifeBond

Series D in 2015
LifeBond is a leader in the development and manufacturing of bio-surgical medical devices for tissue repair that are intended to improve the recovery of patients and to create an environment that supports the body’s natural healing process and promotes tissue repair. Of natural origin, elastic, adhesive, durable and yet absorbable, the company’s devices can be used to fill a long list of unmet surgical needs. LifeBond’s first product, LifeSeal™, is designed to provide staple-line reinforcement in bariatric and colorectal operations. It was recently studied in an international pilot clinical study in Europe. The company’s second pipeline product, LifeMesh™, a self-fixating hernia mesh, is in pre-clinical development. Other pipeline products include tissue adhesives and absorbable hemostats. LifeSeal™, LifeMesh™ and other LifeBond™ products are investigational and have not yet been approved for sale in the US or in any other market. For more information please visit use at: www.life-bond.com
Aquarius Engines designs, develops, and builds an advanced engine to generate electric power. Its integrated power system overcomes disadvantages of hybrid and electric cars, making them affordable, efficient, and eliminating recharging anxieties. Aquarius Engines’ integrated power system is composed of a combustion engine and an electricity generator. Its product simplifies manufacturing processes and production costs. Aquarius Engines was founded in 2014.

CyberX

Seed Round in 2014
Funded by Norwest Venture Partners, Qualcomm Ventures and other leading venture firms, CyberX delivers the only cybersecurity platform built by blue-team experts with a track record of defending critical national infrastructure. That difference is the foundation for the most widely deployed platform for continuously reducing IoT/OT risk and preventing costly outages, safety and environmental incidents, theft of intellectual property, and operational inefficiencies. For more information, visit CyberX.io or follow @CyberX_Labs.

Outbrain

Series E in 2013
Outbrain is a recommendation platform for the open web. Their technology enables online consumers to discover new things through recommendation feeds on their media and connects advertisers to audiences for their businesses. Their advertising platform helps connect brands with consumers.

LifeBond

Series C in 2011
LifeBond is a leader in the development and manufacturing of bio-surgical medical devices for tissue repair that are intended to improve the recovery of patients and to create an environment that supports the body’s natural healing process and promotes tissue repair. Of natural origin, elastic, adhesive, durable and yet absorbable, the company’s devices can be used to fill a long list of unmet surgical needs. LifeBond’s first product, LifeSeal™, is designed to provide staple-line reinforcement in bariatric and colorectal operations. It was recently studied in an international pilot clinical study in Europe. The company’s second pipeline product, LifeMesh™, a self-fixating hernia mesh, is in pre-clinical development. Other pipeline products include tissue adhesives and absorbable hemostats. LifeSeal™, LifeMesh™ and other LifeBond™ products are investigational and have not yet been approved for sale in the US or in any other market. For more information please visit use at: www.life-bond.com

Outbrain

Series C in 2011
Outbrain is a recommendation platform for the open web. Their technology enables online consumers to discover new things through recommendation feeds on their media and connects advertisers to audiences for their businesses. Their advertising platform helps connect brands with consumers.

Digiflex

Series B in 2010
DigiFlex offers a revolutionary inkjet CtP solution, transforming the quality of analog photopolymeric plates for the flexographic, letterpress, dry-offset and rotary silk screen printing technologies, to the digital era. -The first really affordable Computer-to-Plate solution for quality in-house plate making -Ideal for narrow web applications printers -A great motivation to replace the traditional low quality film solution -The propriety, revolutionary, Bi-component ink is the result of years of research by top scientists and technologists with excellent printing industry track

VisionSense

Venture Round in 2009
Visionsense develops novel visualization solutions that bring natural stereoscopic sight to minimally invasive surgery (MIS). With advanced sensor technology and proprietary software, the Visionsense system delivers depth perception, 3D-HD resolution images and maneuvering flexibility through the smallest access diameters. Existing Minimally Invasive Surgery (MIS) vision solutions provide 2D (monocular) images that lack depth perception. This restricts the surgeon’s perspective limiting the ability to perform advanced MIS procedures. With stereovision capabilities, surgeons gain enhanced tissue understanding, improved hand eye coordination and the confidence to use advanced (articulating) surgical tools.

Outbrain

Series B in 2009
Outbrain is a recommendation platform for the open web. Their technology enables online consumers to discover new things through recommendation feeds on their media and connects advertisers to audiences for their businesses. Their advertising platform helps connect brands with consumers.

GigaTrust

Series E in 2008
GigaTrust is a leading SaaS provider of endpoint email security and document in-use protection for on premise private cloud or private cloud based deployments for Windows, iOS and Android devices. GigaTrust is the largest and oldest provider that enhances and extends Microsoft’s Rights Management Services (RMS) content security solution. Customers rely on GigaTrust’s innovative next generation content security technologies, combined with ease of use and deployment, to enable intellectual property protection and confidentiality. The company’s flagship offering, GigaCloud™, delivers secure email and document collaboration services anytime, anywhere, on virtually any device and any platform with real-time data analytics, reporting and administrative tools. It applies and enforces security permissions down to the digital content level, protecting content from misuse throughout the entire lifecycle—while in transit, at rest and, most importantly "in use”. For more information about GigaTrust, visit www.gigatrust.com.

Outbrain

Series A in 2008
Outbrain is a recommendation platform for the open web. Their technology enables online consumers to discover new things through recommendation feeds on their media and connects advertisers to audiences for their businesses. Their advertising platform helps connect brands with consumers.

LifeBond

Series A in 2007
LifeBond is a leader in the development and manufacturing of bio-surgical medical devices for tissue repair that are intended to improve the recovery of patients and to create an environment that supports the body’s natural healing process and promotes tissue repair. Of natural origin, elastic, adhesive, durable and yet absorbable, the company’s devices can be used to fill a long list of unmet surgical needs. LifeBond’s first product, LifeSeal™, is designed to provide staple-line reinforcement in bariatric and colorectal operations. It was recently studied in an international pilot clinical study in Europe. The company’s second pipeline product, LifeMesh™, a self-fixating hernia mesh, is in pre-clinical development. Other pipeline products include tissue adhesives and absorbable hemostats. LifeSeal™, LifeMesh™ and other LifeBond™ products are investigational and have not yet been approved for sale in the US or in any other market. For more information please visit use at: www.life-bond.com

Quigo

Venture Round in 2007
Quigo is an ad-targeting network that provides contextual advertising services for many large media websites including ABCNews.com, CNNMoney.com, Forbes.com, and USAToday.com. Quigo is a direct competitor to Google's contextual advertising program, Adsense. Quigo [sold](http://www.techcrunch.com/2007/11/07/aol-buys-quigo-confirmed/) to AOL for $340 million and will become part of its Platform-A advertising solution.

Outbrain

Seed Round in 2007
Outbrain is a recommendation platform for the open web. Their technology enables online consumers to discover new things through recommendation feeds on their media and connects advertisers to audiences for their businesses. Their advertising platform helps connect brands with consumers.

hipix

Venture Round in 2007
Human Monitoring, Ltd. provides software based video processing solutions. The company focuses on offering video and image processing solutions for embedded platforms and PCs. It offers CoDecs for the Philips PNX 13xx, PNX 15xx, and 8550 platforms; Fresco, video mosaics stitching product; Leonardo, a digital video stabilizer; and Mattisse, a PC AVC RT video encoder. The company was founded in 2004 and is based in Givat Hashlosha, Israel.

Mobileye

Private Equity Round in 2006
Mobileye leads the mobility revolution with its autonomous-driving and driver-assist technologies, harnessing world-renowned expertise in computer vision, machine learning, mapping, and data analysis. Our technology enables self-driving vehicles and powers industry-leading driver assistance systems to optimize mobility infrastructure.

Mempile

Series C in 2005
Mempile developed removable storage technology for the healthcare, public, entertainment, security, financial & business sectors. It focused on developing optical storage that is designed to hold up to one Terabyte of information on a single removable disc. The company offered its products for use in applications, such as home archiving, entertainment, public sector, business compliance, healthcare & video monitoring. Mempile had a development center in the United States & a business development unit in Japan. Mempile was founded in 2000 and was based in Yehuda, Israel. It closed down as of January 2009.

Mobileye

Series B in 2003
Mobileye leads the mobility revolution with its autonomous-driving and driver-assist technologies, harnessing world-renowned expertise in computer vision, machine learning, mapping, and data analysis. Our technology enables self-driving vehicles and powers industry-leading driver assistance systems to optimize mobility infrastructure.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.